CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME

This adverse event was reported 20 times

These drugs are most commonly taken by patients reporting CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME:

# Drug Count
0 CANAKINUMAB 13
1 ANAKINRA 9
2 METHOTREXATE 3
3 METHOTREXATE SODIUM 3
4 COLCHICINE 2
5 IBUPFROFEN 2
6 IBUPROFEN 2
7 IBUPROFEN 200 MG 2
8 IBUPROFEN 200MG 2
9 IBUPROFEN CAPSULE 2
See all common drugs associated with CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME

CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANAKINUMAB 13 0.0012
1 ANAKINRA 9 0.0005
2 MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN 1 0.0005
3 ZINC OXIDE OINTMENT 1 0.0005
4 ZINC OXIDE 1 0.0005
5 SKIN PROTECTANT 1 0.0004
6 TESTOSTERONE CYPIONATE 1 0.0001
7 COLCHICINE 2 0.0001
8 CLARITHROMYCIN 1 0.0000
9 AZATHIOPRINE 1 0.0000
See all drugs enriched for association with CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME

CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 9 0.0005
1 Nitrogen Binding Agent [EPC] 1 0.0004
2 Alkaloid [EPC] 2 0.0001
3 Macrolide Antimicrobial [EPC] 1 0.0000
4 Purine Antimetabolite [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 Vitamin C [EPC] 1 0.0000
9 Corticosteroid [EPC] 3 0.0000
See all drug classes enriched for association with CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME